Cover of: Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics | Read Online
Share

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics

  • 951 Want to read
  • ·
  • 2 Currently reading

Published by elsevier .
Written in English


Book details:

ID Numbers
Open LibraryOL25717886M
ISBN 109780123948106

Download Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics

PDF EPUB FB2 MOBI RTF

Get this from a library! Nonclinical development of novel biologics, biosimilars, vaccines, and specialty biologics. [Lisa M Plitnick; Danuta J Herzyk;].   Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals. Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics: : Plitnick, Lisa: Books.

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics Edited by Lis M Plitnick and Danuta J Herzyk. Academic Press, ISBN: ; pp; $ (hardback) In 15 chapters (covered in 4 sections), this book brings nonclinical testing of biological and follow-on biological drugs, vaccines plus.   KWH. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics PdF. Detail Author: Pages: pages Publisher: Academic Press Language: English ISBN. nonclinical development of novel biologics, biosimilars, vaccines and specialty biologics edited by lisa m. plitnick, ms, phd and danuta j. herzyk, phd merck research laboratories, merck & co., inc. west point, pa, usa elsevier amsterdam • boston • heidelberg • london new york • oxford • paris • san diego.   Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics , Pages Chapter 9 - Global Regulatory Guidelines for Vaccines.

Marque D. Todd, Maggie Dempster, Regulatory Guidelines and their Application in the Nonclinical Evaluation of Biological Medicines, Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics, /B, (), (). Plitnick, L.M. () Global Regulatory Guidelines for Vaccines. In Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics, Academic Press, Cambridge, Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies takes a look at the current strategies, successes and challenges involved with the development of novel formulations of biologics, vaccines and cancer thorough reference on the latest trends in the development of diverse modalities will appeal to a broad community of scientists, students and . Lisa is co-editor of a book entitled Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics and has written and/or contributed to several book chapters on Title: Distinguished Scientist at Merck.